ATC codes: J01EE01
Infectious cystitis ICD11 code: GC80.1
Sulfamethoxazole + trimethoprim
Medicine type
Chemical agent
Antibiotic groups
List type
Parenteral > General injections > IV: 80 mg + 16 mg per mL in 10 mL ampoule ; 80 mg + 16 mg per mL in 5 mL ampoule
Oral > Liquid: 200 mg + 40 mg per 5 mL oral liquid
Oral > Solid: 100 mg + 20 mg tablet ; 400 mg + 80 mg tablet ; 800 mg + 160 mg tablet (EML)
Oral > Solid > dispersible tablet: 100 mg + 20 mg
EML status history
First added in 2017 (TRS 1006)
Changed in 2021 (TRS 1035)
Changed in 2023 (TRS 1049)
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Expert Committee recommendation
The Expert Committee recommended the inclusion of a new strength, child-friendly dispersible tablet formulation of amoxicillin + clavulanic acid (200 mg + 28.5 mg) as an Access group antibiotic on the core list of the EMLc for treatment of bacterial infections in children – specifically those infections for which amoxicillin + clavulanic acid is already recommended on the EMLc. The Committee noted that the 7:1 ratio of amoxicillin to clavulanic acid is associated with similar efficacy to the 4:1 ratio but has a reduced frequency of gastrointestinal adverse effects. The Committee endorsed the importance of age-appropriate formulations to better meet the dosing needs of children. Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended: - the addition of a new formulation of amoxicillin + clavulanic acid (dispersible tablet 250 mg + 62.5 mg) to the EMLc. - the addition of a new strength formulation of nitrofurantoin (solid oral dosage form 50 mg) on the EMLc. - the addition of a new strength formulation of sulfamethoxazole + trimethoprim (dispersible tablet 100 mg + 20 mg) on the EMLc.
EML recommendations: Infectious cystitis